These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8092888)

  • 1. Frequency and treatment of ovarian cysts in adolescence.
    Porcu E; Venturoli S; Dal Prato L; Fabbri R; Paradisi R; Flamigni C
    Arch Gynecol Obstet; 1994; 255(2):69-72. PubMed ID: 8092888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study to illustrate the benefits of using ethinyl estradiol-cyproterone acetate over metformin in patients with polycystic ovarian syndrome.
    Mhao NS; Al-Hilli AS; Hadi NR; Jamil DA; Al-Aubaidy HA
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S95-8. PubMed ID: 26703220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papillophlebitis associated with the use of oral contraceptive: a case report.
    Eski Yücel O; Güngor I; Gül A; Turgut M; Aritürk N
    Gynecol Endocrinol; 2015; 31(8):601-3. PubMed ID: 26291803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The hypocrisy of Diane®].
    Revuz J
    Ann Dermatol Venereol; 2013 Apr; 140(4):249-50. PubMed ID: 23567222
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral contraception vs insulin sensitization for 18 months in nonobese adolescents with androgen excess: posttreatment differences in C-reactive protein, intima-media thickness, visceral adiposity, insulin sensitivity, and menstrual regularity.
    Ibáñez L; Díaz M; Sebastiani G; Marcos MV; López-Bermejo A; de Zegher F
    J Clin Endocrinol Metab; 2013 May; 98(5):E902-7. PubMed ID: 23547047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of an oral contraceptive containing cyproterone acetate (Diane-35) on the symptoms, hormone profile, and ovarian volume of hirsute women with polycystic ovarian syndrome.
    Prelević GM; Puzigaća Z; Balint-Perić LA
    Ann N Y Acad Sci; 1993 May; 687():255-62. PubMed ID: 8323181
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effectiveness of oral cyproterone acetate in combination with ethinylestradiol in acne tarda of the facial type].
    Gollnick H; Albring M; Brill K
    Ann Endocrinol (Paris); 1999 Sep; 60(3):157-66. PubMed ID: 10520404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized crossover study of medroxyprogesterone acetate and Diane-35 in adolescent girls with polycystic ovarian syndrome.
    Chung JP; Yiu AK; Chung TK; Chan SS
    J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):166-71. PubMed ID: 24656700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diane 35 and spironolactone combination in the treatment of hirsutism.
    Kelestimur F
    Clin Endocrinol (Oxf); 2001 May; 54(5):699-700. PubMed ID: 11380503
    [No Abstract]   [Full Text] [Related]  

  • 10. Doppler analysis of ovarian stromal blood flow changes after treatment with metformin versus ethinyl estradiol-cyproterone acetate in women with polycystic ovarian syndrome: A randomized controlled trial.
    Sahu A; Tripathy P; Mohanty J; Nagy A
    J Gynecol Obstet Hum Reprod; 2019 May; 48(5):335-339. PubMed ID: 30316907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic cyproterone/ethinyloestradiol for acne.
    Greenwood R; Burke B; Brummitt L; Cunliffe WJ
    Lancet; 1983 Oct; 2(8353):796. PubMed ID: 6137631
    [No Abstract]   [Full Text] [Related]  

  • 12. [Inhibition of ovulation with 35 micrograms of ethinyl estradiol and 2 mg of cyproterone acetate (Diane 35)].
    Spona J; Huber J; Schmidt JB
    Geburtshilfe Frauenheilkd; 1986 Jul; 46(7):435-8. PubMed ID: 3093307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A cyproterone acetate-ethinyl estradiol combination in the treatment of acne. Data of a survey of gynecologists].
    Vignini M; Pelfini C; Montanari L
    Minerva Ginecol; 1988 Feb; 40(2):125-32. PubMed ID: 2969466
    [No Abstract]   [Full Text] [Related]  

  • 14. Results of an open one-year study with Diane-35 in women with polycystic ovarian syndrome.
    Golland IM; Elstein ME
    Ann N Y Acad Sci; 1993 May; 687():263-71. PubMed ID: 8323182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian cysts in children and adolescents: their occurrence, behavior, and management.
    Kanizsai B; Orley J; Szigetvári I; Doszpod J
    J Pediatr Adolesc Gynecol; 1998 May; 11(2):85-8. PubMed ID: 9593607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of efficacy of Diane-35 in androgenetic feminine alopecia].
    Brzezińska-Wcisło L
    Wiad Lek; 2003; 56(3-4):202-5. PubMed ID: 12923971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How medical treatment affects mean platelet volume as a cardiovascular risk marker in polycystic ovary syndrome?
    Kabil Kucur S; Gozukara I; Aksoy A; Uludag EU; Keskin H; Kamalak Z; Carlioglu A
    Blood Coagul Fibrinolysis; 2015 Dec; 26(8):862-5. PubMed ID: 25402193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic cyproterone/ethinyloestradiol for acne.
    Lancet; 1983 Aug; 2(8347):458. PubMed ID: 6135942
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclic cyproterone/ethinyloestradiol in acne.
    Bye P
    Lancet; 1983 Oct; 2(8355):910-1. PubMed ID: 6137719
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.
    Franks S; Layton A; Glasier A
    Hum Reprod; 2008 Feb; 23(2):231-2. PubMed ID: 18083746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.